A four-day 'World Congress on Ovulation Induction & Ovarian Stimulation Protocols' was held in Jaipur from August 7 to 10, informed Dr. Vandana Narula via facebook posting and pictures.
The participants discussed the controlled ovarian stimulation (COS) with gonadotropins to produce multiple follicular development and high-quality oocytes is the cornerstone of assisted reproductive technology. It was stressed that COS protocols can now be individualized to optimize efficacy and safety defined as singleton pregnancies with a low incidence of ovarian hyperstimulation syndrome.
Developments in biomarkers and other techniques for accurate identification of viable oocytes and embryos and optimal uterine receptivity were the focus of deliberation during the conference. According to the organizers, Inter-individual variation in ovarian response represents a significant clinical and economical challenge. Undoubtedly, there is a need to reliably predict ovarian response to stimulation, to tailor stimulation protocols optimizing the probability of pregnancy and keep at the same time the risks of complications and costs at a minimum.
The topics such as ovarian stimulation strategies; primary, secondary and tertiary prevention of OHSS; development of protocols for patients with diminished ovarian reserve; ovarian reserve testing and its practical implications; mild stimulation and financial implications; segmentation of IVF treatment; impact of ovarian stimulation on the endometrium; and emergency stimulation for onco-fertility patients were discussed with latest research findings and current evidence-based recommendations to achieve the best outcomes.
It was informed that special emphasis needs to be given on how to avoid excessive response and predict the occurrence of ovarian hyperstimulation syndrome (OHSS), as well as on maximizing tolerability of treatment from a patient's perspective.